Researchers at Case Western Reserve University have added to the growing body of understanding about how hydroxychloroquine (HCQ) is not a possible defense against COVID-19. Specifically, they found that HCQ is not effective in preventing COVID-19 in patients with lupus and rheumatoid arthritis (RA), suggesting a broader interpretation of HCQ as ineffective preventive medicine for the general population. Their findings were recently published in the Annals of the Rheumatic Diseases.
- Better diet and glucose uptake in the brain lead to longer life in fruit flies
- Rapid blood test identifies COVID-19 patients at high risk of severe disease
- New study connects religiosity in US South Asians to cardiovascular disease
- USask study finds COVID isolation worsens student diets, inactivity, and alcohol intake
- Scientists offer road map to improve environmental observations in the Indian Ocean